Tullamore transplant teenager celebrates second vaccine

After a year of trepidation, three kidney transplant teenagers came out of cocooning on Thursday, 8 April when they attended Beaumont Hospital for an unprecedented cause for celebration. The former patients at Temple Street Children’s Hospital are among the first in the revised Group 4 classified to be in the ‘very high-risk’ to receive their second and final ‘shot in the arm’ of the Pfizer/BioNTech vaccine, against Covid-19.   

With the changes that were brought in last month, revised group 4 was extended from 18-69 years to include 16 and 17 year olds. With the Pfizer-BioNTech vaccine being the only one currently approved for 16 and 17 year olds the three teens were added to the list and their vaccination will now allow them to return to school with a greater sense of confidence.